Analyst firms · BofA Securities · ZGN

BofA Securities ZGN price target and rating history

Ermenegildo Zegna N.V. (ZGN) · Consumer Discretionary

BofA Securities rates Ermenegildo Zegna N.V. (ZGN) Neutral with a $11.20 price target, as of its latest action on Jan 16, 2026. It has published 5 rating actions on ZGN since September 2022, including 2 upgrades and 2 downgrades. Across 9 firms with a ZGN price target in the last 12 months, the median target is $13. BofA Securities's $11.20 is 14% below that.

Current rating
Neutral
Price target
$11.20
Median target, all firms
$13
Actions on ZGN
5

BofA Securities price target on ZGN

$17$13$9.802023202420252026
BofA Securities price target on ZGN, each point a stated target, September 2022 to January 2026.

Every BofA Securities rating on ZGN

How other firms rate ZGN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
RBC Capital MarketsOutperform$16Oct 27, 2026
HSBCBuy$16Oct 6, 2026
BNP Paribas ExaneUnderperform$12.20Aug 11, 2026
Goldman SachsNeutral$14Jun 17, 2026
TD CowenBuy$15May 20, 2026
Morgan StanleyEqual-Weight$11Feb 12, 2026
UBSBuy$11.50Feb 5, 2026
BofA SecuritiesNeutral$11.20Jan 16, 2026
BernsteinOutperform$13Nov 25, 2025

Questions about BofA Securities and ZGN

What is BofA Securities's price target for ZGN?
BofA Securities's latest stated price target for Ermenegildo Zegna N.V. (ZGN) is $11.20, from its action on Jan 16, 2026.
What is BofA Securities's rating on ZGN?
BofA Securities rates ZGN Neutral, a neutral rating, as of Jan 16, 2026.
When did BofA Securities last change its view on ZGN?
On Jan 16, 2026, BofA Securities downgrades to Neutral from Buy, price target $11.20.
How does BofA Securities's ZGN target compare with other analysts?
Across 9 firms with a ZGN price target in the last 12 months, the median target is $13. BofA Securities's $11.20 is 14% below that.

More ZGN rating histories

All BofA Securities ratingsZGN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.